Evidence map›Paper›PMID 32280229›Full record

ArticleNeuropsychiatric disease and treatment2020

Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI).

Takashi Tsuboi, Takefumi Suzuki, Takaharu Azekawa, Naoto Adachi, Hitoshi Ueda, Kouji Edagawa, Eiichi Katsumoto, Yukihisa Kubota, Eiichiro Goto, Seiji Hongo and 7 more

Open access · goldAbstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2020
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Takashi TsuboiDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.ORCID 0000-0002-8253-8888
Takefumi SuzukiThe Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan.ORCID 0000-0002-5147-1684
Takaharu AzekawaThe Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan.
Naoto AdachiThe Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan.
Hitoshi UedaThe Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan.
Kouji EdagawaThe Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan.
Eiichi KatsumotoThe Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan.
Yukihisa KubotaThe Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan.ORCID 0000-0002-9837-6799
Eiichiro GotoThe Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan.
Seiji HongoThe Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan.
Yoichiro WatanabeThe Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan.
Masaki KatoThe Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan.ORCID 0000-0001-6727-7272
Norio Yasui-FurukoriThe Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan.
Reiji YoshimuraThe Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan.
Atsuo NakagawaThe Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan.ORCID 0000-0002-2294-2571
Toshiaki KikuchiThe Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan.
Koichiro WatanabeDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
Japanese Society of Clinical Neuropsychopharmacology · JPKeio University · JPKyorin University · JPKansai Medical University · JPUniversity of Occupational and Environmental Health Japan · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to identify factors associated with non-remission in bipolar disorder. PATIENTS AND

methodsThe multicenter treatment survey for bipolar disorder in psychiatric outpatient clinics (MUSUBI) study used a questionnaire administered at 176 clinics throughout Japan from September to October 2016. Clinic psychiatrists performed a retrospective medical record survey of consecutive cases with bipolar disorder. Patients were considered to be in remission if they met all of the following criteria: they were not in a mixed state, their manic or depressive symptoms were either borderline or nonexistent (corresponding to 2 or 1 points on the Clinical Global Impressions Scale, Bipolar Version), and their psychiatrists clinically considered them to be in remission. Enrolled patients were classified into remitters group and non-remitters group and demographic and clinical characteristics were contrasted between the groups. Non-remitters were compared with remitters, using a series of logistic regression analyses.

resultsA total of 3130 patients (1420 men; mean age: 50.3 years) were included in this study; 1307 patients (41.8%) were in remission. Of the remaining 1823 patients, 1260 (40.3%) had mild to severe depression, 261 (8.3%) suffered from manic or hypomanic episodes, and 302 (9.6%) were in a mixed state. Logistic regression analyses found the following eight factors to be significantly correlated with non-remission in patients with bipolar disorder: female gender, younger age, unemployed status, rapid cycling pattern, comorbid alcohol/substance abuse, poorer social function, lithium non-use, and antidepressant use.

conclusionThe MUSUBI study, the largest nationwide investigation on bipolar disorder, identified eight clinically relevant factors associated with non-remission in bipolar patients. They have important clinical implications; further prospective studies are necessary to replicate these findings and to guide better managements for those in serious needs.

Indexed as

antipsychoticsbipolar disordermood stabilizernationwide studynon-remission

Identifiers

PMID32280229
PMCPMC7127845
OpenAlexW3013291528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.